Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center ; day:12 ; month:08 ; year:2023
South Asian journal of cancer ; (12.08.2023)
- Beteiligte Personen und Organisationen
-
Indhuja, Muthiah Vaikundaraja
Kesana, Sivasree
Mehra, Nikita
Karunakaran, Parathan
Rajan, Arun Kumar
Radhakrishnan, Venkatraman
Jayachandran, Perumal Kalaiyarasi
- DOI
-
10.1055/s-0042-1758353
- URN
-
urn:nbn:de:101:1-2023092811203954807461
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Indhuja, Muthiah Vaikundaraja
- Kesana, Sivasree
- Mehra, Nikita
- Karunakaran, Parathan
- Rajan, Arun Kumar
- Radhakrishnan, Venkatraman
- Jayachandran, Perumal Kalaiyarasi
Ähnliche Objekte (12)
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)
Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)
Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
ALK + anaplastic large cell lymphoma involving the bladder: case report and review of the literature
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)